The Ministry of Education is launching the Common University Entrance Test (CUET exam 2023 UG) for all undergraduate programs offered by Central Universities for the 2023-24 academic year. The purpose of the test is to create a level playing field and equal opportunities for candidates from different regions, particularly those from rural or remote areas. The single entrance examination will allow candidates to have a wider reach and be considered for admission to multiple Central Universities.

CUET Exam 2023 UG Highlights

Important deadlines- CUET Exam 2023 UG last date

Scheme of CUET Exam 2023 UG

1. 1. From the above subjects / languages, the candidate can choose maximum of 10 subjects from
      all three Sections.

1. 1. Examination will be conducted on multiple days in three shifts, depending on the number of
      Candidates and Subject choices.

 

 

Syllabus for CUET Exam 2023 UG

CUET Application Fees 2023

CUET Exam 2023 UG Admit Card

The National Testing Agency will make the CUET admit cards available on the official website cuet.samarth.ac.in in the second week of May. To obtain the admit card, candidates must log in with their CUET application ID and password. The admit card will contain important information such as the exam center location, date, and time, as well as instructions. It is crucial that candidates print a copy of the admit card and keep it secure until the admission process is finished.

Participating Universities in CUET Exam 2023 UG

A total of 90 universities, made up of 44 central universities and 46 state, deemed, and private universities, are participating in CUET 2023. The scores from the CUET UG exams will be accepted by all of these universities for admission into various CUET programs. These programs include undergraduate courses such as B.A., B.Com, B.Sc, BBA, BCA, and integrated postgraduate courses. The number of seats available for each course in each college will vary. A list of all participating central universities can be found below.

On Sunday, November 14, 2021, India's first grass conservatory, with a two-acre footprint, opened in Ranikhet, Almora district of Uttarakhand. The conservatory was built in three years by the Uttarakhand Forest Department's research arm with funding from the Central Government's CAMPA scheme.

What is a grass conservatory?

In the protection area, almost 90 different grass species of major scientific, ecological, medicinal, and cultural importance have been grown. There are seven different types of grass species in the protected area, including those used for fragrant, medicinal, feed, ornamental, agricultural, and religious purposes. The project's goal is to raise awareness about grass species' value, encourage their protection, and make field research easier.

What is the need for grass conservatory?

It's also crucial because grasslands are under assault from a variety of sources, and their acreage is declining, putting an entire ecosystem of insects, birds, and mammals that rely on them in jeopardy. Because of their nutritious grain and soil-forming function, grasses are the most economically important of all flowering plants. The endeavour is significant since recent research has shown that grasslands are more effective at 'carbon sequestration' than forest areas.

Thysanolaena, popularly known as Tiger grass or Broom grass, is a valuable fodder grass found in Uttarakhand along steep slopes, ravines, and sandy riverbanks up to an elevation of 2000 metres.

Broom is made from its dry blooming stocks. Because it is a perennial species, it can be utilised as green fodder all year. It also aids in soil erosion prevention on steep hillsides and is employed in land restoration.

Pennisetum Purpureum, often known as Elephant grass or Napier grass, makes a great contour hedgerow as well as bank and pasture feed. Used for firebreaks, windbreaks, and bio-oil, biogas, and charcoal production.

Other worth reading articles for you - 1) State of PhD in India
2) Love-hate relationship among mosquitoes towards light

Online application for kumaun university phd entrance exam known as Research degree entrance test (RDET) 2021 are out now.

5. Selection procedure, written exam, and interview

1. To test the research aptitude of the candidate in related subject a written examination of 100 marks shall be conducted by the University. The total duration of this examination shall be of 02 hrs.
2. Question paper shall contain 100 objective/multiple-choice type questions and each question shall carry one mark with no negative marking.
3. RDET will be followed by an interview of 100 marks at the respective department which will be conducted by HOD & Convener of the respective department.
4. The Qualifying Percentage of Marks in the written Entrance Examination will be:- Unreserved-50%, OBC-45% and SC/ST/VH/PH - 40%.
5. The candidates who qualify the written examination the final merit will be prepared in accordance with 70% weightage of the marks obtained in written entrance examination plus 30% weightage of the marks obtained in interview.

6. Download Admit Card for Kumaun University PhD 2021 Exam

The download link will be available 7 days before the entrance exam.

7. Free online mock test for kumaun university phd entrance exam RDET 2021

8. Online application for RDET 2021

9. RDET 2021 PhD entrance exam information brochure

First antimalarial drug Mosquirix

The World Health Organisation (WHO) has approved the first antimalarial vaccine RTS, S/AS01 (Mosquirix™) in the world.

The World Health Organization has finally approved the world’s first antimalarial drug. Why is this such a big deal? Well, I’ll tell you why, every two minutes a child dies of malaria and this vaccine can save that child and millions of others. The vaccine is called RTS,S (trade name Mosquirix), it is 40% effective and that too not against all types of malaria parasites. This vaccine targets the parasite that’s most common in Africa- Plasmodium falciparum. It’s a 4 dose vaccine with all doses given between the 5th and the 18th month of a child.

How long did it take for the World Health Organisation to recommend this vaccine? The European Medicines Agency authorized it in 2015 but the WHO sat on it for six years.

How long did the development of an antimalarial drug take? Centuries. Malaria has been claiming lives since the Mesopotamian civilization. In the 20^th century alone malaria claimed nearly 300 million lives.

Malaria was not the priority of western countries?

Then why did it take so long to develop a vaccine? Was science not in its favour? Well, the problem was not science, the problem was with lack of political desire. You see research needs money and push but the countries devastated by malaria are the world’s poorest mostly African countries where a lot of families cannot even afford a mosquito net. Malaria was not the priority of the West.

Let us talk some numbers, there are 229 million cases of malaria every year 94% of these cases are reported in Africa. The continent records more than 400,000 malaria deaths every year and most of these victims are children. Outside Africa, less than 90,000 people lose their lives to malaria every year so the world chooses to not care.

Malaria vs Wuhan virus vaccine

In contrast, consider the Wuhan virus it affects rich countries too. In 2020 the western world was suffering, the economy was suffering so companies deep-dived into research and governments poured billions of dollars to create vaccines on priority. The US alone donated $9 billion for COVID development in 2020. What about the malaria vaccine the entire world pulled together $7.3 billion in malaria research from 2007 to 2018 that’s less than a billion dollars every year.

Yes, the malaria parasite is more complicated than the Wuhan virus but the story for the extremely delayed development of a malaria vaccine does not end there. The truth is that a malaria vaccine has never really been a priority. We saw how the covid vaccine smashed all records, we were rolling out doses at speed one couldn’t imagine in the pharmaceutical world. The world made not one not two more than 22 Wuhan virus vaccines in 20 months. Seven of them have already been given emergency use authorization by the World Health Organisation, 124 others are in clinical development stage 194 in preclinical trial and this is not a cooked up story, it’s the data from WHO.

What explains the speed is that the vaccine makers, the approvers, the donors all had the required incentive. These vaccines had a market, a malaria vaccine does not have a market this big. Africa is a continent of 1.3 billion people that’s the population of India. Demand for a malaria vaccine is concentrated in just sub-Saharan Africa. WHO estimates say there could be a requirement of 110 million doses per year by 2036 that’s not a big market not big enough for pharma giants to book their resources. There is also not enough money to be made with the sale of each dose.

GSK partners with Bharat bioetch in the production of first antimalarial drug

GSK or GlaxoSmithKline the company producing the malaria vaccine has said that it will price the jab at 5% above the cost of production. 15 million annual doses will be produced for now and these vaccines will also be made in India. GSK has partnered with India’s Bharat biotech. Another vaccine called R21 is in stage three of clinical trials, it is being developed by Oxford University it will be made by the serum institute of India.

Conclusion

That’s all very well but could all of this have been fast-tracked? had malaria overwhelmed in the hospitals of New York, Italy, Spain or China perhaps the story would have been different and we sincerely hope it doesn’t spread to these parts. That’s not what we’re saying what we’re trying to say is that malaria for Africa is worse than covid. Malaria killed 386,000 Africans in 2019 the Wuhan virus killed 212,000 in the last 18 months.

Because all of this is happening in Africa it never makes it to the headlines but now that we know how fast vaccines can be developed let’s try to not be blinded by profit. The world should apply this urgency to develop vaccines for other diseases too. Vaccines are a lifesaver and we have come a long way, we defeated smallpox, polio but there is still no long term vaccine for tuberculosis, West Nile, Zika, HIV, the malaria vaccine we say is a great start but there's a long way to go.

Suggested content to read

1. The love-hate relationship of mosquito towards the light

2. State of PhD in India